Medication Safety of Elderly Patients in Hospital and Ambulatory Setting Considering the Transitions of Care for Home-cared Patients and Nursing Home Residents

RWTH Aachen University1 site in 1 country61 target enrollmentApril 2012

ConditionsElderly Pharmaceutical Care Hospital Readmission Health Services for the Aged Medication Safety

Overview

Phase: Not Applicable
Intervention: Not specified
Conditions: Elderly
Sponsor: RWTH Aachen University
Enrollment: 61
Locations: 1
Primary Endpoint: Drug-related readmission
Status: Completed
Last Updated: 10 years ago

Overview Investigators Eligibility Criteria Outcomes Sites Similar Trials

Overview

Brief Summary

The purpose of this study is to determine whether additional pharmaceutical care for elderly patients (home-cared patients, nursing-home residents) has a positive impact on drug-related readmissions.

Registry

clinicaltrials.gov

Start Date

April 2012

End Date

April 2014

Last Updated

10 years ago

Study Type

Interventional

Study Design

Parallel

Sex

All

Investigators

Sponsor

RWTH Aachen University

Responsible Party

Sponsor

Eligibility Criteria

Inclusion Criteria

•patient 65 years old or older
•patient admitted to one of the project wards
•minimum hospitalization: 3 days
•written informed consent (patient or the legal representative)
•current medication of the patient at hospitalization

Exclusion Criteria

•patients included in this study previously

Outcomes

Primary Outcomes

Drug-related readmission

Time Frame: one year after discharge from the cooperating ward

Secondary Outcomes

time for intervention(during hospital stay on cooperating wards (continuous data collection during routine ward rounds; hence, duration of data collection is dependent on individual hospital stay of each patient, up to one year) in the intervention group)
number of changes in medication after discharge(one year)
Adverse drug events(during hospital stay on cooperating wards(continuous data collection during routine ward rounds;hence,duration of data collection is dependent on individual hospital stay of each patient, up to 1 year) and 1 year after discharge from the cooperating ward)
Number of prescribed potentially inappropriate medication (PRISCUS-criteria)(during hospital stay on cooperating wards(continuous data collection during routine ward rounds;hence,duration of data collection is dependent on individual hospital stay of each patient, up to 1 year) and 1 year after discharge from the cooperating ward)
time to readmission(one year after discharge from the cooperating ward)
Number of accepted recommendations in the intervention group(during hospital stay on cooperating wards (continuous data collection during routine ward rounds; hence, duration of data collection is dependent on individual hospital stay of each patient, up to one year) in the intervention group)
drug-related problem(during hospital stay on cooperating wards (continuous data collection during routine ward rounds; hence, duration of data collection is dependent on individual hospital stay of each patient, up to one year) in the intervention group)